Johnson & Johnson JNJ has one of the most diverse revenue streams in the industry within the pharmaceutical division called ...

This trial evaluated the safety and efficacy of the combination of Regeneron’s Lynozyfic (linvoseltamab), a B-cell maturation ...

Verity & Verity LLC increased its stake in Amgen by 4% during Q1, bringing its total holdings to over $29 million. Amgen now ...

Amgen Inc. (NASDAQ: AMGN) is one of the 11 most profitable NASDAQ stocks to buy now. On June 2, Amgen announced new interim ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

In the latest close session, Amgen (AMGN) was up +1.88% at $297.29. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated ...

The U.S. Court of Appeals for the Third Circuit issued a precedential opinion in a case arising out of a somewhat obscure ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.